Utama › Gangguan Saraf Periferi › Maryland
Kajian klinikal Gangguan Saraf Periferi di Maryland
7 kajian untuk Gangguan Saraf Periferi sedang mencari peserta di lokasi di Maryland.
Bandar di Maryland
Teks kajian rasmi (Bahasa Inggeris)
Study of Inherited Neurological Disorders
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 120 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT00004568Investigational Use of Neuromuscular Ultrasound
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 110 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05237973PT-112 in Subjects With Thymoma and Thymic Carcinoma
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 2
Umur 18 hingga 120 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05104736This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
- Curtis National Center at MedStar Union Memorial Hospital, Baltimore
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06616025WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
- Johns Hopkins Hospital, Baltimore
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT05950659A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
- Medstar Union Memorial Hospital- The Curtis National Hand Center, Baltimore
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT06529835Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
- Sami Tuffaha, Baltimore
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT03150511Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.